慢性荨麻疹患者接受Omalizumab治疗的血液学和炎症生物标志物的评估

{"title":"慢性荨麻疹患者接受Omalizumab治疗的血液学和炎症生物标志物的评估","authors":"E. Dogan, A. Aktaş","doi":"10.5336/DERMATO.2021-81209","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":39132,"journal":{"name":"Turkiye Klinikleri Dermatoloji","volume":"31 1","pages":"28-35"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of Hematological and Inflammatory Biomarkers in Patients Receiving Omalizumab Treatment in Chronic Urticaria\",\"authors\":\"E. Dogan, A. Aktaş\",\"doi\":\"10.5336/DERMATO.2021-81209\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":39132,\"journal\":{\"name\":\"Turkiye Klinikleri Dermatoloji\",\"volume\":\"31 1\",\"pages\":\"28-35\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Turkiye Klinikleri Dermatoloji\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5336/DERMATO.2021-81209\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkiye Klinikleri Dermatoloji","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5336/DERMATO.2021-81209","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}